Aperio Group’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-14,316
Closed -$294K 2428
2019
Q4
$294K Sell
14,316
-6,310
-31% -$131K ﹤0.01% 2070
2019
Q3
$514K Buy
20,626
+4,110
+25% +$87.8K ﹤0.01% 1744
2019
Q2
$334K Sell
16,516
-6,174
-27% -$134K ﹤0.01% 1978
2019
Q1
$532K Buy
22,690
+1,843
+9% +$46.6K ﹤0.01% 1722
2018
Q4
$423K Buy
+20,847
New +$569K ﹤0.01% 1779
2017
Q4
Sell
-3,782
Closed -$217K 2266
2017
Q3
$217K Sell
3,782
-435
-10% -$21.7K ﹤0.01% 2088
2017
Q2
$218K Buy
4,217
+410
+11% +$21.1K ﹤0.01% 2061
2017
Q1
$204K Buy
3,807
+87
+2% +$4.94K ﹤0.01% 2031
2016
Q4
$230K Buy
+3,720
New +$206K ﹤0.01% 1926

Other funds holding LDL

Aperio Group's LDL Position: Q1 2020 in Review

Aperio Group sold out of Lydall, Inc. (LDL) in Q1 2020, closing a stake of 14,316 shares — an estimated $294K sold.

Aperio Group first reported a position in LDL in Q4 2016 and held it in 9 quarters. The position peaked at $532K in Q1 2019. 123 funds tracked by Wall St. Rank hold LDL as of Q1 2020.

  • Aperio Group reported no remaining Lydall, Inc. position as of Q1 2020 after selling out during the quarter.
  • Aperio Group sold 14,316 Lydall, Inc. shares in Q1 2020, an estimated $294K.
  • Aperio Group first reported a position in Lydall, Inc. in Q4 2016 and held it in 9 quarters.
  • Aperio Group's Lydall, Inc. position peaked at $532K in Q1 2019.
  • 123 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2020.

Based on Aperio Group's 13F filing for Q1 2020, filed 5 May 2020.